5-HT 1A receptors are one of the most promising targets for the development of novel antipsychotics.

Choosing the optimal drug therapy for an acute psychotic episode has become much more complex, particularly with the advent of the novel antipsychotics. Now, physicians must carefully consider the ...

The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...

(Lancet Psychiatry) Investigational LB-102 -- a potential first-in-class benzamide antipsychotic -- significantly improved schizophrenia symptoms after 4 weeks with all three doses tested in a ...